research Mercury rising
This article discusses Dr. Jane Hightower's findings on mercury poisoning linked to fish consumption in patients and reports no new clinical results; it highlights ongoing debate and regulatory actions.
Search
forResearch
5 / 1000+ results
research What to Look for in Red Light Therapy: A Product Guide Backed by Science
This review discusses the mechanisms, scientific support, and FDA clearance of photobiomodulation mask devices but reports no new research findings.
research Mercury Rising
This article discusses Dr. Jane Hightower's findings on the link between mercury exposure from fish consumption and health symptoms, sparking international debate and influencing regulatory advisories, but reports no new clinical results.
research A Radiation Oncologist Writes
This article discusses ethical concerns in medicine around high physician incomes and the rush to adopt expensive technologies like proton beam therapy without clear clinical benefits, without reporting new research findings.
research Raising hairs
Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.
Community Join
5 / 1000+ resultscommunity Topical Fin & Min, 5 Month Progress
Significant hair regrowth was achieved using a topical combination of 0.3% finasteride and 6% minoxidil, with weekly dermastamping and ketoconazole shampoo, without side effects. Others suggested additional treatments like red light therapy and PRP.
community Finally, some real breakthroughs. A comparison of the two leading baldness treatments: PP405 versus ABS-201
PP405 and ABS-201 are promising treatments for male pattern baldness. PP405 shows rapid hair growth in human trials, while ABS-201 shows significant regrowth in animal studies but is still in early human trials.
community FDA Policy Shift Explained: What It Actually Means for PP405, VDPHL-01, Breezula and Hair Loss Drug Timelines
The FDA policy change may speed up approval for hair loss drugs like PP405, VDPHL-01, and Breezula by potentially eliminating the need for a second confirmatory Phase 3 trial. Approval timelines could be as early as 2028 for some treatments if Phase 3 results are strong.
community US FDA will now default to only one clinical trial for drug applications, will this accelerate the release of PP405 and other drugs in clinical trials?
The FDA will now require only one clinical trial for drug approval, potentially speeding up the release of hair loss treatments like PP405. Pelage is expected to present full results of PP405 Phase 2a trials and move to Phase III in mid-2026.
community New warning by FDA on topical finasteride
The FDA warned that topical finasteride can cause serious side effects like sexual dysfunction and brain fog, similar to oral finasteride. Compounded topical formulations pose additional risks due to lack of regulation.
Learn
— no results
Experts
— no results
Clinics
— no results